Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia

Background: A randomised, double-blind, placebo-controlled study evaluated lipid- and glucose-lowering effects of colesevelam in patients with prediabetes and primary hyperlipidaemia. We report the effect of colesevelam on lipoprotein particle concentration and particle size (determined by nuclear m...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2013

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/23847

Acceso en línea:

https://doi.org/10.1177/1479164112461657
https://repository.urosario.edu.co/handle/10336/23847

Palabra clave:

Colesevelam
High density lipoprotein
Lipoprotein
Low density lipoprotein
Low density lipoprotein cholesterol
Triacylglycerol
Very low density lipoprotein
Article
Atherogenesis
Cardiovascular risk
Cholelithiasis
Cholesterol blood level
Controlled study
Cystocele
Drug efficacy
Drug safety
Erectile dysfunction
Female
Human
Hyperlipidemia
Hypoglycemia
Impaired glucose tolerance
Intention to treat analysis
Lipoprotein blood level
Major clinical study
Male
Nuclear magnetic resonance spectroscopy
Oral glucose tolerance test
Ovary polycystic disease
Particle size
Patient preference
Randomized controlled trial (topic)
Triacylglycerol blood level
Adult
Allylamine
Constipation
Diarrhea
Double-blind method
Dyspepsia
Female
Humans
Hydroxymethylglutaryl-coa reductase inhibitors
Hyperlipidemias
Intention to treat analysis
Lipoproteins
Male
Particle size
Prediabetic state
Triglycerides
Apolipoprotein
Colesevelam
Lipoprotein particles
Low-density lipoprotein
Prediabetes
Primary hyperlipidaemia
vldl
ldl
hdl
biomolecular
Cholesterol
Lipoproteins
Lipoproteins
Nuclear magnetic resonance

Rights

License

Abierto (Texto Completo)